These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3282423)

  • 1. Intraocular lymphoma: report of three cases and review of the literature.
    Trudeau M; Shepherd FA; Blackstein ME; Gospodarowicz M; Fitzpatrick P; Moffatt KP
    Am J Clin Oncol; 1988 Apr; 11(2):126-30. PubMed ID: 3282423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy.
    Berenbom A; Davila RM; Lin HS; Harbour JW
    Eye (Lond); 2007 Sep; 21(9):1198-201. PubMed ID: 16732210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary central nervous system lymphoma report of 32 cases and review of the literature.
    Dubuisson A; Kaschten B; Lénelle J; Martin D; Robe P; Fassotte MF; Rutten I; Deprez M; Stevenaert A
    Clin Neurol Neurosurg; 2004 Dec; 107(1):55-63. PubMed ID: 15567554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraocular lymphoma--a clinical study of 14 patients with non-Hodgkin's lymphoma].
    Ríhová E; Sisková A; Jandusová J; Kovarík Z; Sach J; Adam P
    Cesk Slov Oftalmol; 2004 Jan; 60(1):3-16. PubMed ID: 15011301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
    Mason JO; Fischer DH
    Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical review: treatment of vitreoretinal lymphoma.
    Pe'er J; Hochberg FH; Foster CS
    Ocul Immunol Inflamm; 2009; 17(5):299-306. PubMed ID: 19831557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
    Hormigo A; Abrey L; Heinemann MH; DeAngelis LM
    Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes.
    Hoffman PM; McKelvie P; Hall AJ; Stawell RJ; Santamaria JD
    Eye (Lond); 2003 May; 17(4):513-21. PubMed ID: 12802353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?
    Restrepo A; Raez LE; Byrne GE; Johnson T; Ossi P; Benedetto P; Hamilton K; Whitcomb CC; Cassileth PA
    Crit Rev Oncog; 1998; 9(3-4):269-73. PubMed ID: 10201631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
    Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M;
    J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
    Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
    Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
    J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy associating systemic platinum-based chemotherapy and local radiotherapy into the treatment of primary intraocular lymphoma.
    Tempescul A; Pradier O; Marianowski-Cochard C; Ianotto JC; Berthou C
    Ann Hematol; 2011 Sep; 90(9):1117-8. PubMed ID: 21184080
    [No Abstract]   [Full Text] [Related]  

  • 20. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.